Ultrasound assessment of fetal cardiac function.
Fàtima Crispi, Brenda Valenzuela-Alcaraz, Monica Cruz-Lemini...
https://pubmed.ncbi.nlm.nih.gov/28191192/Actively Recruiting
Led by Anna Erenbourg · Updated on 2024-12-10
495
Participants Needed
7
Research Sites
4 weeks
Total Duration
Researchers are studying automated fetal heart function parameters to see if they differ between healthy babies and those with congenital heart disease. This international multicenter observational study aims to find out if these automated measurements can better predict heart complications like hydrops compared to current cardiovascular scores. The study focuses on pregnancies with and without fetal heart defects to compare cardiac function over time. Participants will have two fetal cardiac function ultrasound scans one between 27 weeks and 29 weeks plus 6 days of pregnancy, and another between 34 weeks and 36 weeks plus 6 days. These scans use both clinical and advanced research ultrasound systems to capture detailed heart measurements, including heart size, valve function, blood flow, and contractility. The study collects images and data securely and follows participants until delivery and hospital discharge. During the study, women will undergo standard pregnancy ultrasounds alongside research scans assessing various heart function parameters. Researchers will analyze these detailed images and functional data to compare healthy and affected fetuses. They will also evaluate if adding automated measures improves prediction of complications like hydrops. Data confidentiality is maintained, and results will be published while protecting patient privacy. The entire pregnancy period is observed, with data collected at two specific gestational windows.
CONDITIONS
Automated Fetal Cardiac Function in Babies Affected by Heart Diseases
A
Anna Erenbourg, MD
A
Alec W Welsh, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Anna Erenbourg
Lead Sponsor
Centre Hospitalier de Mayotte
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Up to 8 weeks (from approximately 19 weeks + 6 days to 27 weeks + 6 days of gestation)
Participants are screened for eligibility to participate in the trial.
Screening and enrollment visit
Duration - From 27 weeks + 6 days to 36 weeks + 6 days of gestation
Participants undergo fetal cardiac function echocardiography to evaluate automated ultrasound parameters including cardiac morphology and function at two specified gestational age windows.
2 visits (in-person) between 27+6 - 29+6 weeks and 34+6 - 36+6 weeks gestation
Duration - Until delivery and hospital discharge
Participants are followed up until delivery and discharge of mother and neonate to collect pregnancy and birth outcomes information.
Follow-up through standard prenatal and postnatal care visits; visit schedule varies
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Fàtima Crispi, Brenda Valenzuela-Alcaraz, Monica Cruz-Lemini...
https://pubmed.ncbi.nlm.nih.gov/28191192/Shobha Natarajan, Anita Szwast, Zhiyun Tian...
https://pubmed.ncbi.nlm.nih.gov/23473605/R Axt-Fliedner, O Graupner, A Kawecki...
https://pubmed.ncbi.nlm.nih.gov/25418127/Priya Maheshwari, Amanda Henry, Alec W Welsh
https://pubmed.ncbi.nlm.nih.gov/26185751/O Graupner, C Enzensberger, L Wieg...
https://pubmed.ncbi.nlm.nih.gov/26138790/Yilmaz Yozgat, Ayhan Kilic, Rahmi Ozdemir...
https://pubmed.ncbi.nlm.nih.gov/24749803/S R F F Pedra, L K Hornberger, S M Leal...
https://pubmed.ncbi.nlm.nih.gov/16132314/Cheryl Mei Jun Tan, Adam James Lewandowski
https://pubmed.ncbi.nlm.nih.gov/31533099/Youfang Chen, Guorong Lv, Boyi Li...
https://pubmed.ncbi.nlm.nih.gov/19023852/Ganesh Acharya, Nick Archer, James C Huhta
https://pubmed.ncbi.nlm.nih.gov/17885470/Anna Erenbourg
Lead Sponsor
Centre Hospitalier de Mayotte
Collaborating Sponsor